Questions for 9/26

1. Who qualifies to participate in clinical trials?

2. Does the government or FDA have any guidelines on developing numerous drugs for one disease? For example, "There are already too many drugs for blood pressure, we do not need any more on the market."

3. On the other hand, are there any incentives to creating and manufacturing one drug for a certain disease over another?

Comments